Increasing Use Of Medical Marijuana

Increasing Use Of Medical Marijuana

There has been a significant rise in the use of medical marijuana over recent years, sparking ongoing debates and extensive research among scientists and policymakers. The core question revolves around whether the medicinal benefits of marijuana outweigh potential risks, and if legalization is justified based on scientific evidence. This paper examines the scientific, ethical, and social perspectives surrounding the increasing use of medical marijuana, with particular focus on its therapeutic benefits, legal implications, and societal impact.

Historically, marijuana has been classified as an illicit Schedule I drug by the United States Drug Enforcement Agency (DEA), indicating that it was regarded as having no accepted medical use and a high potential for abuse. However, scientific research conducted in the late 20th and early 21st centuries has challenged this categorization. Clark (2000) highlights that a report by a team of independent scientists appointed by the Institute of Medicine demonstrated that marijuana could be effective in alleviating some debilitating symptoms associated with serious illnesses. Specifically, marijuana has been shown to reduce nausea and vomiting in chemotherapy patients, control pain, combat wasting in AIDS patients, and relieve muscle spasms linked to multiple sclerosis. These findings suggest that marijuana possesses genuine therapeutic value, which should be considered when evaluating its legal status.

The scientific evidence discussed by Clark emphasizes that the initial classification of marijuana as a Schedule I drug may no longer be justified. Furthermore, the report indicates no evidence to suggest that increased medical use of marijuana acts as a gateway to other illegal drug use. Nonetheless, despite compelling scientific data, federal restrictions have remained unchanged for decades, limiting physicians’ ability to prescribe standardized medicinal cannabis. Clark (2000) argues that reevaluating marijuana’s classification could facilitate more accessible treatment options for patients suffering from chronic illnesses, thus respecting their right to effective care. Importantly, the ethical considerations point towards balancing government restrictions with patients’ rights to medical treatment, which should be prioritized in policymaking.

Research by Sidney (2001) focuses specifically on marijuana use among HIV-positive and AIDS patients. The study highlights that a significant proportion of these patients utilize marijuana to manage symptoms such as nausea, pain, and appetite loss. Using data from surveys conducted across California, Sidney reports that approximately 33.3% of respondents currently used medical marijuana. Participants praised the drug for improving mental health, reducing stress, increasing appetite, and alleviating nausea. These findings reinforce the notion that medical marijuana plays a critical role in improving the quality of life for patients with severe health conditions. Such evidence underscores the importance of legal frameworks that allow safe and regulated access to medicinal cannabis, emphasizing compassion and patient-centered care.

Of particular interest is whether the legalization of medical marijuana influences its usage among adolescents. Lynne-Landsman, Livingston, and Wagenaar (2013) investigate this issue by analyzing data from the Youth Risk Behavior Survey from 2003 to 2011. Their research employs a difference-in-differences approach to evaluate whether the implementation of Medical Marijuana Laws (MMLs) in various states increases marijuana consumption among teenagers. The findings reveal that in the initial years after MML enactment, there was no significant rise in adolescent marijuana use. This evidence counters arguments that legalization directly leads to increased youth consumption and suggests that with proper regulation, medicinal marijuana can be made accessible without elevating the risk of adolescent drug abuse.

Despite these encouraging findings, the broader societal implications of increasing marijuana use warrant careful consideration. Critics often raise concerns about potential addiction, impaired cognitive development in youth, and the normalization of drug use. Nonetheless, scientific and clinical research supports the notion that when used responsibly and within regulated frameworks, medical marijuana offers substantial benefits that can outweigh potential harms. Policymakers need to consider scientific evidence alongside ethical and social factors to develop balanced legislation that safeguards public health while ensuring patients' access to necessary therapies.

In conclusion, the increasing use of medical marijuana is backed by scientific findings indicating its efficacy in managing several debilitating health conditions. Removing unnecessary legal barriers could improve patient outcomes and uphold the ethical obligation to provide effective healthcare. Furthermore, evidence suggests that legalization does not necessarily lead to increased adolescent drug use when properly regulated. Therefore, ongoing research, ethical scrutiny, and cautious policy reform are essential to integrate medical marijuana into mainstream healthcare responsibly. As society progresses, it is crucial to align legal frameworks with scientific knowledge to maximize therapeutic benefits and minimize risks.

References

• Clark, P. A. (2000). The ethics of medical marijuana: Government restrictions vs. medical necessity. Journal of Public Health Policy, 21(1), 40-60.
• Lynne-Landsman, S. D., Livingston, M. D., & Wagenaar, A. C. (2013). Effects of state medical marijuana laws on adolescent marijuana use. American Journal of Public Health, 103(8). https://doi.org/10.2105/AJPH.2012.301117
• Sidney, S. (2001). Marijuana use in HIV-positive and AIDS patients. Journal of Cannabis Therapeutics, 1(3-4), 35-41.
• Hall, W., & Weier, M. (2015). Assessing the public health impacts of legalizing recreational cannabis use in the United States. Clinical Pharmacology & Therapeutics, 97(6), 607-615.
• Pacula, R. L., & Smart, R. (2017). Medical marijuana and marijuana legalization. JAMA, 317(2), 159-160.
• Bachhuber, M. A., Saloner, B., Cunningham, C. O., & Barry, C. L. (2014). Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999–2010. JAMA Internal Medicine, 174(10), 1668–1673.
• Reiman, A., LeGrand, G., & Jetl, N. (2017). Cannabis as a substitute for prescription drugs and other substances. Frontiers in Pharmacology, 8, 382.
• National Academies of Sciences, Engineering, and Medicine. (2017). The health effects of cannabis and cannabinoids: The current state of evidence and recommendations for research. National Academies Press.
• Hall, W. (2014). The adverse health effects of cannabis use. New South Wales Public Health Bulletin, 25(3-4), 72-75.
• Volkow, N. D., & McLellan, A. T. (2016). The role of science in addressing the opioid epidemic. JAMA, 315(17), 1825-1826.